Clinical and immune characteristics of rapid dropout and long-term survival in a phase II safety and efficacy study of combination CRS-207/GVAX immunotherapy in pancreatic cancer.

@article{Le2016ClinicalAI,
  title={Clinical and immune characteristics of rapid dropout and long-term survival in a phase II safety and efficacy study of combination CRS-207/GVAX immunotherapy in pancreatic cancer.},
  author={Dung T Le and Chan C. Whiting and Eric Robert Lutz and Nitya Nair and Amanda Engstrom and Ed Lemmens and Margit Cecile Tagliaferri and Aimee Luck Murphy and Dirk G. Brockstedt and Elizabeth M Jaffee},
  journal={Journal of Clinical Oncology},
  year={2016},
  volume={34},
  pages={459-459}
}

Topics from this paper.

Similar Papers

Loading similar papers…